Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

eLife(2024)10.7554/elife.92559.1Source: DataRank Database

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer is a research paper published in eLife (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Varvara Kirillov ORCID,Oleksi Petrenko ORCID,Nancy C. Reich ORCID,Stephen D’Amico ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W4391361102

National Cancer Institute

Grant: RO1CA236389

National Institutes of Health

Grant: 1R01CA236389-01A1

STAT3 is a Critical Regulator of Tumor Cell Plasticity

goldLicense: cc-by

journalhttps://doi.org/10.7554/elife.92559.1

publisherhttps://doi.org/10.7554/elife.92559.1

publisherhttps://cdn.elifesciences.org/preprints/92559/elife-preprint-92559-v1.pdf

publisherhttps://cdn.elifesciences.org/preprints/92559/elife-preprint-92559-v1.xml

publisherhttps://elifesciences.org/reviewed-preprints/92559v1/pdf

Fields of Study

Pancreatic and Hepatic Oncology ResearchCancer Cells and MetastasisTGF-β signaling in diseases03 medical and health sciences0302 clinical medicine

Keywords

KRASMutantPancreatic cancerTGF beta signaling pathwayCancer researchBETA (programming language)CancerTransforming growth factor betaMutationInternal medicineOncologyBiologyTransforming growth factorMedicineGeneticsGeneComputer scienceSTAT3 Transcription FactorEpithelial-Mesenchymal TransitionQH301-705.5Sciencecancer dependencyQRArticleSTAT3Pancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Transforming Growth Factor beta1Cell Line, Tumorepithelial carcinogenesisHumansBiology (General)PancreasCancer Biology

Sustainable Development Goals

SDG 0: Good health and well-being